ISG20

ISG20 Full Name

interferon stimulated exonuclease gene 20kDa

ISG20 Introduction

Interferon-stimulated gene 20 kDa protein (ISG20) is a 3'-to-5' exoribonuclease that plays a pivotal role in the innate immune response against viral infections. It is a member of the DEDD (Asp-Glu-Asp-Asp) superfamily of exonucleases and is one of the many genes whose expression is potently induced by type I interferons (IFN-α and IFN-β). ISG20 exerts its antiviral activity by directly degrading single-stranded RNA (ssRNA) and, to a lesser extent, DNA. Its primary function is to restrict the replication of a broad spectrum of RNA viruses, including influenza A virus, hepatitis B virus (HBV), and human immunodeficiency virus (HIV), making it a critical component of the cell's intrinsic antiviral defense machinery.

Figure 1. Mechanism of ISG20.

Mechanism of Action and Antiviral Activity
ISG20's antiviral function is primarily dependent on its exonuclease activity. Upon interferon stimulation, ISG20 is upregulated and localizes to the cytoplasm, where it can interact with viral RNA. Its primary mechanism involves binding to and processively degrading viral RNA from the 3' end, thereby preventing viral replication and protein synthesis. Interestingly, ISG20 is also found within nuclear speckles, suggesting it may have additional roles in the processing or turnover of cellular RNA. The enzyme's activity is highly specific, and its importance is underscored by the observation that many viruses have evolved mechanisms to counteract ISG20 function, often through viral proteins that sequester or degrade the enzyme, highlighting its significance in the host-virus arms race.

Clinical Significance and Potential in Therapeutics
Beyond its established role in antiviral defense, emerging research has linked ISG20 to various other biological processes and pathological conditions. Its aberrant expression has been observed in several cancers, where it can act as a tumor suppressor or, conversely, promote tumor progression depending on the cellular context. Furthermore, genetic variations in the ISG20 gene have been associated with susceptibility to autoimmune diseases, suggesting its involvement in modulating the immune response. The potent antiviral activity of ISG20 makes it an attractive target for the development of broad-spectrum antiviral therapeutics. Strategies aimed at enhancing or stabilizing ISG20 activity could provide a novel approach to combat viral infections, particularly against emerging RNA viruses. Additionally, its role in cancer and autoimmunity positions it as a potential biomarker and a target for future drug development in these areas.

Alternate Names for ISG20

ISG20; interferon stimulated exonuclease gene 20kDa; interferon stimulated gene (20kD); interferon-stimulated gene 20 kDa protein; CD25; HEM45; estrogen-regulated transcript 45 protein; promyelocytic leukemia nuclear body-associated protein ISG20;